Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Donepezil on Cognition in PD-MCI
NCT02450786Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jun 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI), sponsored by Yonsei University. Status: unknown.
02
Drugs
donepezil
03
Conditions
Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI)
Beyond the preview
Go deeper on NCT02450786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450786.